Exane Derivatives’s Banco Santander Chile BSAC Stock Holding History

Exane Derivatives’s Portfolio BSAC Stock Details BSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3	Closed	-$66	–	587
2016 Q4	$66	Sell	3 -2,547	-100%	-$55.7K	﹤0.01%	565
2016 Q3	$52.8K	Sell	2,550 -15,500	-86%	-$324K	0.01%	297
2016 Q2	$350K	Buy	18,050 +734	+4%	+$13.9K	0.06%	162
2016 Q1	$335K	Sell	17,316 -1,607	-8%	-$28.4K	0.04%	161
2015 Q4	$334K	Sell	18,923 -13,129	-41%	-$244K	0.05%	137
2015 Q3	$584K	Buy	32,052 +31,877	+18,215%	+$623K	0.07%	116
2015 Q2	$3.54K	Hold	175	–	–	﹤0.01%	400
2015 Q1	$3.79K	Sell	175 -22,148	-99%	-$449K	﹤0.01%	410
2014 Q4	$440K	Buy	+22,323	New	+$476K	0.06%	152

Other funds holding BSAC

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Exane Derivatives's BSAC Position: Q1 2017 in Review

Exane Derivatives sold out of Banco Santander Chile (BSAC) in Q1 2017, closing a stake of 3 shares — an estimated $66 sold.

Exane Derivatives first reported a position in BSAC in Q4 2014 and held it in 9 quarters. The position peaked at $584K in Q3 2015. 134 funds tracked by Wall St. Rank hold BSAC as of Q1 2017.

Exane Derivatives reported no remaining Banco Santander Chile position as of Q1 2017 after selling out during the quarter.
Exane Derivatives sold 3 Banco Santander Chile shares in Q1 2017, an estimated $66.
Exane Derivatives first reported a position in Banco Santander Chile in Q4 2014 and held it in 9 quarters.
Exane Derivatives's Banco Santander Chile position peaked at $584K in Q3 2015.
134 funds tracked by Wall St. Rank held Banco Santander Chile as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.